Want to see JP:7091 full AI Analyst Report?
Living Platform Ltd. (7091) AI Stock Analysis
Living Platform Ltd.
(TSE/TYO:7091)
The score is driven primarily by improving operating performance but constrained by high leverage and inconsistent cash-flow conversion. Technically, the stock is trading below key moving averages with weak momentum, while valuation (reasonable P/E and dividend yield) provides partial support.
Living Platform Ltd. (7091) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 5.30B
- Dividend Yield
- 0.42%
- Average Volume (3M)
- 14.13K
- Price to Earnings (P/E)
- 11.0
- Beta (1Y)
- 0.26
- Revenue Growth
- 13.29%
- EPS Growth
- 17.57%
- Country
- Japan
- Employees
- 1,326
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Care Facilities
Living Platform Ltd. Business Overview & Revenue Model
Company Description
Established in 2011, Living Platform,Ltd. is a company based in Sapporo, Japan, that provides a range of services encompassing nursing care, childcare, and assistance for individuals with disabilities.
Living Platform Ltd. Financial Statement Overview
Summary
Revenue growth and an EBIT turnaround support improving fundamentals, but the debt-heavy balance sheet (high debt-to-equity) and uneven free-cash-flow conversion reduce financial resilience.
Income Statement
62PositiveBalance Sheet
40NegativeCash Flow
54Neutral| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 22.65B | 22.06B | 19.20B | 16.66B | 13.69B | 11.63B |
| Gross Profit | 2.43B | 2.31B | 1.94B | 1.45B | 1.28B | 1.33B |
| EBITDA | 1.15B | 1.10B | 885.74M | 791.08M | 657.19M | 1.02B |
| Net Income | 482.33M | 396.83M | 365.59M | 189.35M | 91.70M | 407.96M |
Balance Sheet | ||||||
| Total Assets | 13.53B | 13.08B | 12.12B | 11.19B | 11.41B | 10.87B |
| Cash, Cash Equivalents and Short-Term Investments | 1.79B | 1.48B | 1.59B | 1.13B | 1.88B | 1.75B |
| Total Debt | 6.52B | 6.53B | 6.54B | 5.98B | 6.95B | 6.84B |
| Total Liabilities | 10.88B | 10.58B | 10.06B | 9.53B | 9.94B | 9.52B |
| Stockholders Equity | 2.65B | 2.49B | 2.05B | 1.66B | 1.47B | 1.35B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 337.55M | 81.26M | 881.05M | -729.95M | -638.06M |
| Operating Cash Flow | 0 | 871.51M | 612.28M | 1.51B | 93.00M | 443.61M |
| Investing Cash Flow | 0 | -989.72M | -722.06M | -1.26B | -15.55M | -498.01M |
| Financing Cash Flow | 0 | 3.47M | 574.58M | -1.00B | 53.24M | 217.58M |
Living Platform Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7091, the sentiment is Negative. The current price of 1181.00 is below the 20-day moving average (MA) of 1203.95, below the 50-day MA of 1245.10, and below the 200-day MA of 1218.56, indicating a bearish trend. The MACD of -14.16 indicates Positive momentum. The RSI at 41.13 is Neutral, neither overbought nor oversold. The STOCH value of 23.44 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7091.
Living Platform Ltd. Peers Comparison
Overall Rating
JP:922073Outperform
JP:243564Neutral
JP:237357Neutral
JP:242556Neutral- JP:709155Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| JP:9220 | 73Outperform | JPY 3.19B | 7.21 | ― | 3.29% | 5.48% | 13.46% |
| JP:2435 | 64Neutral | JPY 2.27B | 4.70 | ― | 3.96% | 2.01% | 2.55% |
| JP:2373 | 57Neutral | JPY 5.26B | 18.40 | ― | 4.35% | 4.76% | -52.55% |
| JP:2425 | 56Neutral | JPY 2.50B | 29.59 | ― | 3.34% | -5.72% | -73.78% |
| JP:7091 | 55Neutral | JPY 5.30B | 10.97 | ― | 0.42% | 13.29% | 17.57% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:7091 | Living Platform Ltd. | 1181.00 | 205.12 | 21.02% | |
| JP:2373 | Care Twentyone Corporation | 391.00 | -67.03 | -14.63% | |
| JP:2425 | Care Service Co., Ltd. | 658.00 | -120.64 | -15.49% | |
| JP:2435 | Cedar. Co.,Ltd | 202.00 | -14.17 | -6.56% | |
| JP:9220 | FB CARE SERVICE CO.,LTD. | 1308.00 | 86.90 | 7.12% |
Living Platform Ltd. Corporate Events
Living Platform Profit Surges on Rising Occupancy and Record Quarterly Sales
Living Platform, Ltd. reported that occupancy rates continued to improve in the first quarter of FY2027.3, underscoring stronger demand for its residential services and more efficient use of its facility portfolio.Supported by higher occupancy, the c...
Living Platform Delivers Strong Quarterly Profit Growth and Confirms Dividend Outlook
Living Platform reported revenue of ¥5.95 billion for the quarter ended June 30, 2026, up 11.1% year on year, with operating profit surging 79.6% to ¥216 million and profit attributable to owners of parent climbing 87.2% to ¥174 millio...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 30, 2026